99mtc-exametazime-labeled leukocytes
Cell therapyexperimentalImaging agent
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
1
Phase 3
1
Phase 4
0
Earliest trial started Sep 1, 2015 (NCT02538133)
Timeline
2010s
- Jan 1, 2015
Earliest Phase 3 Sponsor(trial)
Indications
Studied for
Mechanism of action
- Unspecified targetRadiopharmaceutical
radiopharmaceutical
Chemistry & pharmacology
- Imaging
- 99-technetium
Oral
No
Parenteral
No
Topical
No
Also known as
- 99mtc-exametazime-labeled leukocytes
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02538133 | Phase 3 | Sep 1, 2015 | University of Angers, University of Antwerp |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Angers | Academic/Hospital | 1 | 0 | 1 | 2015 |
| University of Antwerp | Academic/Hospital | 1 | 1 | 1 | 2015 |
2 organizations
Page 1 / 1